Studies have shown a decrease in 5-HT1B receptor function in patients with major depressive disorder (MDD) [102], and these patients tend to be less sensitive to 5-HT1B agonists, indicating reduced expression or desensitization of 5-HT1B receptors [103]. The gene discussed is HTR1B; the disease is major depressive disorder.